Among patients with NSQ cancer and known EGFR and ALK status, 5304 individuals (40.5%) were WT, 6866 individuals (52.5%) were EGFR-positive, and 914 individuals (7.0%) were ALK-positive. The gene discussed is ALK; the disease is cancer.